Viscoelastic Point-of-Care Testing (ClotPro<sup>®</sup>) to Guide Intravenous Thrombolysis in Acute Ischemic Stroke Patients on DOACs: Replacing History with Hemostasis in a Proof-of-Concept Study.

Neurol Int · 2025 · PMC12299928 · PMID 40710906

Europe PMC DOI

hedged sentences

0.0810

closest p · 1.6× alpha

0.0810

boldest claim

The sentences

a favorable trendp = 0.081so close (0.05 < p ≤ 0.1)

IVT showed a favorable trend for early neurological recovery ( p = 0.081) but was not independently associated with functional outcome ( p = 0.380).

also in 1,335 other papers

a trend toward significancep = 0.081so close (0.05 < p ≤ 0.1)

Predictors of NIHSS-Shift In the multivariable linear regression model, IVT was associated with a favorable NIHSS-shift, showing a trend toward significance (β = −17.53, p = 0.081), consistent with the matched analysis.

also in 3,729 other papers

did not reach statistical significanceno p-value reported

14%, p = 0.119, respectively), but these differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Viscoelastic Point-of-Care Testing (ClotPro&lt;sup&gt;®&lt;/sup&gt;) to Guide Intravenous Thrombolysis in Acute Ischemic Stroke Patients on DOACs: Replacing History with Hemostasis in a Proof-of-Concept Study.

The sentences

Viscoelastic Point-of-Care Testing (ClotPro<sup>®</sup>) to Guide Intravenous Thrombolysis in Acute Ischemic Stroke Patients on DOACs: Replacing History with Hemostasis in a Proof-of-Concept Study.